Digg
Del.icio.us
Newsvine 
Facebook
Stumbleupon
Asterand has signed an agreement to acquire BioSeek, a pioneer in the application of predictive human biology to drug discovery through its human primary cell based disease models.
The deal is subject to Asterand shareholders' approval. Asterand said it achieved revenue of 9.1m in the nine months to the end of September compared with 8m last year - excluding the licensing payments from Allergan.
Revenues for the same period last year also contained 1.1m relating to a one year contract that ended in December 2008.
The company said it continued to control its expenditures while maintaining strong cash resources of 5.2m (30 June: 5.8m).
Story provided by Business Financial Newswire
Shares in British banks rose on the FTSE 100 in morning trading following positive news on the Greek debt crisis.
Unite, the union, has gone to international unions, in its attempts to bring the...
© 2010 The IBTimes Company Ltd. All Rights Reserved.
Partners 
EMAIL
PRINT
RSS
SHARE
